KR102474418B1 - Composition for improving or preventing heartburn - Google Patents
Composition for improving or preventing heartburn Download PDFInfo
- Publication number
- KR102474418B1 KR102474418B1 KR1020200114308A KR20200114308A KR102474418B1 KR 102474418 B1 KR102474418 B1 KR 102474418B1 KR 1020200114308 A KR1020200114308 A KR 1020200114308A KR 20200114308 A KR20200114308 A KR 20200114308A KR 102474418 B1 KR102474418 B1 KR 102474418B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- weight
- heartburn
- food
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 201000006549 dyspepsia Diseases 0.000 title claims abstract description 29
- 208000024798 heartburn Diseases 0.000 title claims abstract description 28
- 150000003839 salts Chemical class 0.000 claims abstract description 39
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 37
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 37
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 37
- 239000011425 bamboo Substances 0.000 claims abstract description 37
- 235000008434 ginseng Nutrition 0.000 claims abstract description 34
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 33
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 33
- 240000002234 Allium sativum Species 0.000 claims abstract description 32
- 235000004611 garlic Nutrition 0.000 claims abstract description 32
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 31
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 31
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims abstract description 31
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 31
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000013376 functional food Nutrition 0.000 claims abstract description 9
- 235000013373 food additive Nutrition 0.000 claims abstract description 8
- 239000002778 food additive Substances 0.000 claims abstract description 8
- 244000082204 Phyllostachys viridis Species 0.000 claims abstract 3
- 239000007788 liquid Substances 0.000 claims description 7
- 241000870644 Drypetes diversifolia Species 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 235000021422 persimmon vinegar Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 241000208340 Araliaceae Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 24
- 235000013305 food Nutrition 0.000 abstract description 19
- 239000002253 acid Substances 0.000 abstract description 8
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 7
- 230000003472 neutralizing effect Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 235000013336 milk Nutrition 0.000 abstract description 4
- 239000008267 milk Substances 0.000 abstract description 4
- 210000004080 milk Anatomy 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 42
- 235000002639 sodium chloride Nutrition 0.000 description 37
- 241001330002 Bambuseae Species 0.000 description 34
- 240000004371 Panax ginseng Species 0.000 description 31
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 9
- 229940069428 antacid Drugs 0.000 description 7
- 239000003159 antacid agent Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000012041 food component Nutrition 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 속쓰림 개선 또는 예방용 조성물에 관한 것으로, 구체적으로 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 포함하는 속쓰림 개선 또는 예방용 기능성 식품 조성물, 또는 식품 첨가제 조성물에 관한 것이다.
본 발명의 조성물은 산 중화 효과 및 항염증 효과가 있으며, 속쓰림을 효과적으로 개선 또는 예방할 수 있다. 특히, 본 발명의 조성물은 주성분이 기존에 안전성이 검증된 식품 재료들로 이루어지므로 소비자들이 부작용에 대한 걱정없이 안전하게 이용할 수 있으며, 식품 또는 식품 첨가물로 제공되면서도 속쓰림에 대한 우수한 개선 또는 예방 효과가 있어 기존 속쓰림에 대한 의약품을 대체하거나 그 사용량을 줄여 의약품 사용에 따른 부담을 줄일 수 있을 것으로 기대된다.The present invention relates to a composition for improving or preventing heartburn, and specifically relates to a functional food composition for improving or preventing heartburn, including wild ginseng, garlic, bamboo salt, milk skin, malt and cabbage, or a food additive composition.
The composition of the present invention has an acid neutralizing effect and an anti-inflammatory effect, and can effectively improve or prevent heartburn. In particular, since the main components of the composition of the present invention are made of food materials whose safety has been previously verified, consumers can use it safely without worrying about side effects, and it has excellent improvement or prevention effects on heartburn while being provided as food or food additives. It is expected to reduce the burden of using medicines by replacing existing medicines for heartburn or reducing their usage.
Description
본 발명은 속쓰림 개선 또는 예방용 조성물에 관한 것으로, 구체적으로 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 포함하는 속쓰림 개선 또는 예방용 기능성 식품 조성물, 또는 식품 첨가제 조성물에 관한 것이다.The present invention relates to a composition for improving or preventing heartburn, and specifically relates to a functional food composition for improving or preventing heartburn, including wild ginseng, garlic, bamboo salt, milk skin, malt and cabbage, or a food additive composition.
속쓰림의 원인으로는 역류성 식도염, 위염, 위궤양, 십이지장궤양, 위암 등이 있다. 일반적인 치료에는 제산제를 많이 사용하는데 이에 따른 부작용에는 알루미늄이 함유된 제산제의 경우 변비, 인 흡수 방해, 무력감, 뼈 손상 등이 있고 마그네슘이 함유된 제산제의 경우 설사, 피로 및 무력감 등이 있다. 또한 장기간 제산제를 복용하다가 중단한 경우에는 위산 분비가 증가할 수 있으며 제산제는 다른 약제의 흡수 및 대사에 영향을 줄 수 있다. 지속적으로 제산제를 복용하는 경우에는 위암 등의 심각한 질병의 진단을 지연시킬 수 있다.Causes of heartburn include reflux esophagitis, gastritis, gastric ulcer, duodenal ulcer, and gastric cancer. In general, antacids are widely used for treatment, and side effects include constipation, inhibition of phosphorus absorption, weakness, and bone damage in the case of aluminum-containing antacids, and diarrhea, fatigue, and weakness in the case of magnesium-containing antacids. In addition, if you stop taking antacids for a long time, secretion of gastric acid may increase, and antacids may affect the absorption and metabolism of other drugs. Continuous use of antacids may delay the diagnosis of serious diseases such as stomach cancer.
따라서 이러한 제산제의 부작용을 줄이고 식품공전에 등재된 안전한 식품 원료를 활용하여 장기간 섭취에도 부작용이 없으며 속쓰림을 효과적으로 개선 또는 예방할 수 있는 기능성 식품의 개발이 절실하다.Therefore, it is urgent to develop a functional food that can reduce the side effects of these antacids and utilize safe food ingredients listed in the Food Code to effectively improve or prevent heartburn without side effects even after long-term intake.
한편, 감기, 치통, 두통, 생리통, 관절염, 척추질관, 근육통, 심혈관질환, 뇌혈관질환에 많이 사용되는 비스테로이드성 소염진통제(NSAIDs, Non Steroidal Anti-Inflammatory Drugs)는 각종 염증을 유도하는 COX-2(cyclooxygenase-2)의 활성을 억제하여 소염진통효과를 발휘한다. 그러나 위염과 위궤양에 따른 속쓰림, 오심, 소화불량과 같은 부작용이 있다.On the other hand, NSAIDs (Non Steroidal Anti-Inflammatory Drugs), which are widely used for colds, toothaches, headaches, menstrual pains, arthritis, spinal vaginal canal, muscle pains, cardiovascular diseases, and cerebrovascular diseases, induce various inflammations such as COX- It suppresses the activity of cyclooxygenase-2 (cyclooxygenase-2) to exert anti-inflammatory and analgesic effects. However, there are side effects such as heartburn, nausea, and indigestion due to gastritis and gastric ulcer.
이에 본 발명자는 NSAIDs의 사용을 식품을 통해 일부 대체할 수 있기를 기대하면서 식품공전에 등재된 안전한 식품 원료를 활용함으로써 부작용의 위험을 줄이고 위염 및 위궤양과 같은 염증성 질환의 개선을 통해 속쓰림 증상을 개선 및 예방할 수 있는 기능성 식품을 개발하고자 하였다.Accordingly, the present inventors hope to partially replace the use of NSAIDs through food, and reduce the risk of side effects by using safe food ingredients listed in the Food Code and improve heartburn symptoms by improving inflammatory diseases such as gastritis and gastric ulcers. and to develop functional foods that can prevent it.
따라서 본 발명의 주된 목적은 안전한 식품 원료를 활용하여 속쓰림의 증상에 대해 우수한 개선 또는 예방 효과를 발휘할 수 있는 기능성 식품 조성물을 제공하는데 있다.Therefore, the main object of the present invention is to provide a functional food composition that can exert excellent improvement or prevention effects on the symptoms of heartburn by utilizing safe food raw materials.
본 발명의 다른 목적은 상기와 같은 기능성 식품 조성물을 바탕으로 속쓰림의 증상에 대해 우수한 개선 또는 예방 효과를 발휘할 수 있는 식품 첨가제 조성물을 제공하는데 있다.Another object of the present invention is to provide a food additive composition capable of exhibiting excellent improvement or prevention effects on the symptoms of heartburn based on the functional food composition as described above.
본 발명의 한 양태에 따르면, 본 발명은 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 포함하는 속쓰림 개선 또는 예방용 기능성 식품 조성물을 제공한다.According to one aspect of the present invention, the present invention provides a functional food composition for improving or preventing heartburn, including wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage.
본 발명의 다른 양태에 따르면, 본 발명은 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 포함하는 속쓰림 개선 또는 예방용 식품 첨가제 조성물을 제공한다.According to another aspect of the present invention, the present invention provides a food additive composition for improving or preventing heartburn, including wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage.
본 발명의 조성물에 있어서, 상기 조성물은 산양삼을 1 내지 10중량%로, 마늘을 20 내지 70중량%로, 죽염을 10 내지 60중량%로, 유백피를 3 내지 30중량%로, 맥아를 1 내지 20중량%로, 양배추를 1 내지 20중량%로 포함하는 것이 바람직하다.In the composition of the present invention, the composition contains wild ginseng at 1 to 10% by weight, garlic at 20 to 70% by weight, bamboo salt at 10 to 60% by weight, milky skin at 3 to 30% by weight, malt at 1 to 20% by weight, preferably containing 1 to 20% by weight of cabbage.
본 발명의 조성물에 있어서, 상기 조성물은 벌꿀, 감식초 및 올리고당 중에서 선택된 하나 이상을 더 포함하는 것이 바람직하다.In the composition of the present invention, the composition preferably further comprises at least one selected from honey, persimmon vinegar and oligosaccharides.
본 발명의 조성물에 있어서, 상기 조성물은 분말, 과립, 정제, 환, 캡슐 또는 액상 형태인 것이 바람직하다.In the composition of the present invention, the composition is preferably in powder, granule, tablet, pill, capsule or liquid form.
본 발명의 조성물은 산 중화 효과 및 항염증 효과가 있으며, 속쓰림을 효과적으로 개선 또는 예방할 수 있다. 특히, 본 발명의 조성물은 주성분이 기존에 안전성이 검증된 식품 재료들로 이루어지므로 소비자들이 부작용에 대한 걱정없이 안전하게 이용할 수 있으며, 식품 또는 식품 첨가물로 제공되면서도 속쓰림에 대한 우수한 개선 또는 예방 효과가 있어 기존 속쓰림에 대한 의약품을 대체하거나 그 사용량을 줄여 의약품 사용에 따른 부담을 줄일 수 있을 것으로 기대된다.The composition of the present invention has an acid neutralizing effect and an anti-inflammatory effect, and can effectively improve or prevent heartburn. In particular, since the main components of the composition of the present invention are made of food materials whose safety has been previously verified, consumers can use it safely without worrying about side effects, and it has excellent improvement or prevention effects on heartburn while being provided as food or food additives. It is expected to reduce the burden of using medicines by replacing existing medicines for heartburn or reducing their usage.
도 1은 본 발명의 일 실시형태에 따른 조성물(실시예 1)의 총 폴리페놀 함량을 산양삼, 마늘, 죽염, 유백피, 맥아 또는 양배추 각각을 단독을 사용한 경우(비교예 1 내지 6)와 비교하여 나타낸 것이다.
도 2는 본 발명의 일 실시형태에 따른 조성물(실시예 1)의 세포독성 실험 결과를 산양삼, 마늘, 죽염, 유백피, 맥아 또는 양배추 각각을 단독을 사용한 경우(비교예 1 내지 6)와 비교하여 나타낸 것이다.
도 3은 본 발명의 일 실시형태에 따른 조성물(실시예 1)의 산 중화효과를 산양삼, 마늘, 죽염, 유백피, 맥아 또는 양배추 각각을 단독을 사용한 경우(비교예 1 내지 6)와 비교하여 나타낸 것이다.
도 4는 본 발명의 일 실시형태에 따른 조성물(실시예 1)의 COX-2 억제효과를 산양삼, 마늘, 죽염, 유백피, 맥아 또는 양배추 각각을 단독을 사용한 경우(비교예 1 내지 6)와 비교하여 나타낸 것이다.
도 5는 본 발명 조성물의 속쓰림 개선 효과를 평가하는데 사용한 설문조사지의 양식을 나타낸 것이다.
도 6은 본 발명의 일 실시형태에 따른 조성물(실시예 1)의 속쓰림 개선 효과 평가 결과를 산양삼, 마늘, 죽염, 유백피, 맥아 또는 양배추 각각을 단독을 사용한 경우(비교예 1 내지 6)와 비교하여 나타낸 것이다.1 is a comparison of the total polyphenol content of a composition according to an embodiment of the present invention (Example 1) with wild ginseng, garlic, bamboo salt, milk bark, malt or cabbage alone (Comparative Examples 1 to 6) It was shown by
Figure 2 compares the cytotoxicity test results of the composition (Example 1) according to an embodiment of the present invention with wild ginseng, garlic, bamboo salt, milk bark, malt or cabbage alone (Comparative Examples 1 to 6) It was shown by
Figure 3 compares the acid neutralizing effect of the composition (Example 1) according to an embodiment of the present invention with that of wild ginseng, garlic, bamboo salt, milk bark, malt or cabbage alone (Comparative Examples 1 to 6) it is shown
Figure 4 shows the COX-2 inhibitory effect of the composition (Example 1) according to an embodiment of the present invention when wild ginseng, garlic, bamboo salt, milk skin, malt or cabbage were used alone (Comparative Examples 1 to 6) and shown in comparison.
Figure 5 shows the form of the questionnaire used to evaluate the heartburn improvement effect of the composition of the present invention.
Figure 6 shows the evaluation results of the heartburn improvement effect of the composition (Example 1) according to an embodiment of the present invention when wild ginseng, garlic, bamboo salt, milky skin, malt or cabbage were used alone (Comparative Examples 1 to 6) and shown in comparison.
본 발명의 조성물은 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 포함하는 것을 특징으로 한다.The composition of the present invention is characterized by comprising wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage.
본 발명의 조성물은 상기와 같은 성분들, 즉 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 함유하고 있어, 산 중화 효과 및 항염증 효과가 있으며, 이를 바탕으로 속쓰림을 효과적으로 개선 또는 예방할 수 있다.The composition of the present invention contains the above ingredients, that is, wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage, and has an acid neutralizing effect and an anti-inflammatory effect, and based on this, heartburn can be effectively improved or prevented. .
특히, 본 발명에 따르면, 상기와 같은 성분들의 조합에 의해 산 중화 효과 및 항염증 효과 뿐만 아니라 실제 속쓰림 개선 효과에서 시너지 효과가 있다. 이는 본 발명의 조성물과 각 성분들 중 하나의 성분을 사용하여 같은 농도 또는 사용량의 조건 하에서 상기 효과를 확인한 실험결과를 바탕으로 한다.In particular, according to the present invention, there is a synergistic effect in the actual heartburn improvement effect as well as the acid neutralization effect and anti-inflammatory effect by the combination of the above components. This is based on the results of experiments confirming the above effects under the same concentration or usage conditions using the composition of the present invention and one of each component.
본 발명의 조성물은 상기 성분들을 그 형태에 제한없이 포함할 수 있다. 예를 들어, 수확 또는 제조된 직후의 형태로 포함할 수 있으며, 가공된 형태로도 포함할 수 있다. 바람직하게는 분쇄물 또는 이 분쇄물의 건조물의 형태로 포함한다.The composition of the present invention may include the above components without limitation in their form. For example, it may be included in the form immediately after harvesting or manufacturing, and may also be included in the processed form. Preferably, it is included in the form of a pulverized product or a dried product of the pulverized product.
산양삼은 산지관리법 제2조 제1호의 산지에서 재배하고, 임업 및 산촌 진흥촉진에 관한 법률 제18조의4에 따른 품질검사에 합격한 오갈피나무과 인삼속 식물을 말하며, 본 발명에서는 이 식물의 뿌리를 사용한다. 바람직하게는 Panax ginseng C.A. Meyer의 뿌리이다. 바람직하게는 1 내지 10년생의 산양삼이고, 보다 바람직하게는 2 내지 6년생의 산양삼이다.Wild ginseng refers to a plant of the ginseng genus of the family Cranberry that is cultivated in the mountainous area under
마늘은 외떡잎식물 백합목 백합과의 여러해살이풀로 학명은 Allium sativum이다. 본 발명에서는 이 식물의 땅속 비늘줄기를 사용한다.Garlic is a perennial plant of the monocotyledonous lily family Liliaceae, and its scientific name is Allium sativum . In the present invention, the underground scales of this plant are used.
죽염은 대나무 통 속에 넣어 구운 소금을 말한다. 본 발명에서는 바람직하게는 천일염을 대나무 통 속에 넣어 구운 소금을 사용하며, 바람직하게는 700℃ 이상의 온도로 굽는 것을 3회 이상 반복한 것, 보다 바람직하게는 5회 이상 반복한 것, 보다 바람직하게는 7회 이상 반복한 것, 보다 바람직하게는 8 내지 10회 반복한 것을 사용한다. 보다 바람직하게는 자죽염(자색 죽염)을 사용한다. 보다 바람직하게는 750 내지 850℃의 온도로 굽는 것을 8회 반복하고, 9회 째에 1300 내지 1500℃의 온도로 구워 용융된 액체를 수득하여 냉각 및 분쇄한 자죽염을 사용한다.Bamboo salt refers to salt that is baked in a bamboo tube. In the present invention, preferably, salt is used by putting sun salt in a bamboo tube and baking it, preferably by repeating baking at a temperature of 700 ° C. or higher 3 or more times, more preferably by repeating 5 or more times, more preferably What was repeated 7 times or more, more preferably what was repeated 8 to 10 times is used. More preferably, purple bamboo salt (purple bamboo salt) is used. More preferably, baking at a temperature of 750 to 850 ° C. is repeated 8 times, and baked at a temperature of 1300 to 1500 ° C. for the ninth time to obtain a molten liquid, cooled and crushed bamboo salt is used.
유백피는 느릅나무과의 왕느릅나무의 코르크층을 벗긴 수피를 말한다.Yubaekpi refers to the bark from which the cork layer is peeled off of the king elm tree of the Elmaceae family.
맥아는 벼과의 대맥의 싹을 내어 말린 것을 말한다. 본 발명에서는 바람직하게는 겉보리의 싹을 틔워 말린 것을 사용한다.Malt refers to the sprouted barley of the Poaceae family and dried. In the present invention, sprouted and dried barley is preferably used.
양배추는 쌍떡잎식물 양귀비목 겨자과의 한해살이 또는 두해살이풀을 말하며, 본 발명에서는 흔히 식용으로 사용하는 잎 부위를 사용한다.Cabbage refers to an annual or biennial of the dicotyledonous plant Papaveraceae mustard family, and in the present invention, leaf parts commonly used for food are used.
본 발명의 조성물 중 각 성분의 비율은 바람직하게는 산양삼 5중량부를 기준으로, 마늘 20 내지 70중량부, 죽염 10 내지 60중량부, 유백피 3 내지 30중량부, 맥아 1 내지 20중량부, 양배추 1 내지 20중량부이다. 보다 바람직하게는 산양삼 5중량부를 기준으로, 마늘 30 내지 70중량부, 죽염 20 내지 60중량부, 유백피 3 내지 30중량부, 맥아 1 내지 20중량부, 양배추 1 내지 20중량부이다. 보다 바람직하게는 산양삼 5중량부를 기준으로, 마늘 40 내지 60중량부, 죽염 20 내지 40중량부, 유백피 3 내지 10중량부, 맥아 3 내지 10중량부, 양배추 1 내지 5중량부이다.The ratio of each component in the composition of the present invention is preferably 20 to 70 parts by weight of garlic, 10 to 60 parts by weight of bamboo salt, 3 to 30 parts by weight of milk bark, 1 to 20 parts by weight of malt, cabbage based on 5 parts by weight of wild ginseng. 1 to 20 parts by weight. More preferably, based on 5 parts by weight of wild ginseng, 30 to 70 parts by weight of garlic, 20 to 60 parts by weight of bamboo salt, 3 to 30 parts by weight of milky skin, 1 to 20 parts by weight of malt, and 1 to 20 parts by weight of cabbage. More preferably, based on 5 parts by weight of wild ginseng, 40 to 60 parts by weight of garlic, 20 to 40 parts by weight of bamboo salt, 3 to 10 parts by weight of milky skin, 3 to 10 parts by weight of malt, and 1 to 5 parts by weight of cabbage.
본 발명의 조성물 중 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추가 차지하는 비율은 바람직하게는 10중량% 이상, 보다 바람직하게는 20중량% 이상, 보다 바람직하게는 30중량% 이상, 보다 바람직하게는 40중량% 이상, 보다 바람직하게는 50중량% 이상, 보다 바람직하게는 60중량% 이상, 보다 바람직하게는 70중량% 이상, 보다 바람직하게는 80중량% 이상, 보다 바람직하게는 90중량% 이상이다.The proportion of wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage in the composition of the present invention is preferably 10% by weight or more, more preferably 20% by weight or more, more preferably 30% by weight or more, more preferably is 40% by weight or more, more preferably 50% by weight or more, more preferably 60% by weight or more, more preferably 70% by weight or more, more preferably 80% by weight or more, more preferably 90% by weight or more to be.
본 발명의 조성물은 바람직하게는 산양삼을 1 내지 10중량%로, 마늘을 20 내지 70중량%로, 죽염을 10 내지 60중량%로, 유백피를 3 내지 30중량%로, 맥아를 1 내지 20중량%로, 양배추를 1 내지 20중량%로 포함한다. 이때 산양삼, 마늘 및 양배추의 비율은 바람직하게는 습식 분쇄물을 기준으로 한다. 보다 바람직하게는 산양삼을 3 내지 7중량%로, 마늘을 30 내지 70중량%로, 죽염을 17 내지 39중량%로, 유백피를 4 내지 10중량%로, 맥아를 3 내지 9중량%로, 양배추를 1 내지 5중량%로 포함한다.The composition of the present invention preferably contains wild ginseng at 1 to 10% by weight, garlic at 20 to 70% by weight, bamboo salt at 10 to 60% by weight, milky skin at 3 to 30% by weight, and malt at 1 to 20%. In weight percent, it includes 1 to 20 weight percent of cabbage. At this time, the ratio of wild ginseng, garlic and cabbage is preferably based on wet grinding. More preferably, 3 to 7% by weight of wild ginseng, 30 to 70% by weight of garlic, 17 to 39% by weight of bamboo salt, 4 to 10% by weight of Milk Peel, 3 to 9% by weight of malt, Cabbage is included at 1 to 5% by weight.
본 발명의 조성물은 상기 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추 이외에도 다른 하나 또는 둘 이상의 성분을 더 포함할 수 있다. 이러한 추가 성분은 식품 또는 식품 첨가제의 맛, 향 등을 위한 것일 수 있으며, 제형화를 용이하게 하기 위한 첨가물일 수 있다. 바람직하게는 벌꿀, 감식초 및 올리고당 중에서 선택된 하나 이상을 포함한다.The composition of the present invention may further include one or two or more other ingredients in addition to the wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage. These additional ingredients may be for taste, aroma, etc. of food or food additives, and may be additives to facilitate formulation. Preferably, it includes at least one selected from honey, persimmon vinegar and oligosaccharides.
본 발명의 조성물은 다양한 형태로 제형화될 수 있다. 예를 들어, 분말, 과립, 정제, 환, 캡슐 또는 액상 형태로 제형화될 수 있다.The composition of the present invention can be formulated in a variety of forms. For example, it may be formulated in powder, granule, tablet, pill, capsule or liquid form.
본 발명의 식품 조성물은 과자류, 당류, 아이스크림 제품류, 유가공품, 식육제품, 어육제품, 두부류 또는 묵류, 식용유지류, 면류, 다류, 음료류, 특수영양식품, 건강기능식품, 조미식품, 얼음, 인삼제품류, 김치절임식품, 건포류 등 다양한 형태일 수 있다.The food composition of the present invention is confectionery, sugars, ice cream products, dairy products, meat products, fish meat products, tofu or jelly, edible oils and fats, noodles, teas, beverages, special nutritional foods, health functional foods, seasoning foods, ice, ginseng products, It can be in various forms, such as pickled kimchi and raisins.
본 발명의 조성물은 주요 성분이 식품공전에 등재된 안전한 식품 원료이므로 섭취량에 별다른 제한은 없으며, 예를 들어 본 발명의 조성물 중 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 합한 양을 기준으로 성인 기준 1인당 하루에 1 내지 50g의 범위로 섭취할 수 있을 것이다.Since the composition of the present invention is a safe food ingredient whose main ingredients are listed in the Food Codex, there is no particular restriction on the amount of intake. It may be consumed in the range of 1 to 50 g per day per adult.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail through examples. Since these examples are intended to illustrate the present invention only, the scope of the present invention is not to be construed as being limited by these examples.
[실시예][Example]
1. 조성물 제조1. Composition Preparation
2 내지 6년생 산양삼을 정제수로 2회 세척한 후 식품용 분쇄기로 분쇄하여 준비하였다.After washing 2 to 6 year old wild ginseng twice with purified water, it was prepared by pulverizing with a food grinder.
마늘은 껍질을 제거하고 정제수로 2회 세척한 후 식품용 분쇄기로 분쇄하여 준비하였다.Garlic was prepared by removing the skin, washing it twice with purified water, and pulverizing it with a food grinder.
서해안 천일염을 왕대나무에 넣고 황토로 마개를 한 후 가열로에 차곡차곡 넣은 다음 소나무 장작불을 사용하여 약 800℃로 약 3시간 동안 가열하고, 남은 소금 기둥을 분쇄하고 이를 다시 새 왕대나무에 넣고 황토로 밀봉하여 가열로에서 800℃로 약 3시간 동안 가열하는 것을 8회 반복한 후, 마지막 9회째에는 송진을 장작불에 투입하면서 1400℃로 가열 온도를 높여 약 2시간 정도 가열하여 소금 기둥이 용융된 액체를 수득하였다. 이 액체를 상온에서 12시간 냉각하고 분쇄하여 죽염(자죽염)을 수득하였다. 이때 가열로는 불을 지피는 부분과 가열할 대상이 적재되는 부분의 사이가 철제망의 형태로 이루어져 장작불의 열기가 천일염이 담긴 왕대나무에 직접적으로 가해지도록 이루어진 것을 사용하였다.After putting the west coast sea salt into a large bamboo tree, plugging it with ocher, putting it in a heating furnace one by one, heating it at about 800℃ for about 3 hours using a pine wood fire, crushing the remaining salt column, putting it back into a new king bamboo, and putting it in red clay After sealing it with a furnace and heating it at 800℃ for about 3 hours in a heating furnace, it was repeated 8 times, and the last 9th time, while putting rosin into a wood fire, the heating temperature was raised to 1400℃ and heated for about 2 hours, so that the salt column melted. A liquid was obtained. This liquid was cooled at room temperature for 12 hours, and then pulverized to obtain bamboo salt (jajuk salt). At this time, the heating furnace was made in the form of a wire mesh between the part where the fire is made and the part where the object to be heated is loaded, so that the heat of the wood fire is directly applied to the bamboo containing bay salt.
유백피는 정제수로 2회 세척한 후 식품용 분쇄기로 분쇄하여 준비하였다.The milky white skin was prepared by washing twice with purified water and then pulverizing with a food grinder.
겉보리를 싹을 틔워 말린 맥아는 정제수로 2회 세척한 후 식품용 분쇄기로 분쇄하여 준비하였다.The malt sprouted and dried was prepared by washing it twice with purified water and pulverizing it with a food grinder.
양배추는 정제수로 2회 세척한 후 식품용 분쇄기로 분쇄하여 준비하였다.Cabbage was prepared by washing twice with purified water and then pulverizing with a food grinder.
상기와 같이 준비된 산양삼, 마늘, 죽염, 유백피, 맥아 및 양배추를 각각 5중량%, 51중량%, 28중량%, 7중량%, 6중량% 및 3중량%로 혼합하여 조성물을 제조하였다. 이때 산양삼, 마늘 및 양배추의 비율은 건조하지 않은 형태의 분쇄물(습식 분쇄물)을 기준으로 하였다.A composition was prepared by mixing 5% by weight, 51% by weight, 28% by weight, 7% by weight, 6% by weight and 3% by weight of wild ginseng, garlic, bamboo salt, milky skin, malt and cabbage prepared as described above, respectively. At this time, the ratio of wild ginseng, garlic, and cabbage was based on non-dried pulverized material (wet pulverized material).
2. 제조된 조성물의 특성 실험2. Characteristics test of the prepared composition
상기 항목 1에서 제조한 조성물을 시료로 사용하였으며, 비교를 위해 조성물의 재료 각각을 비교시료로 사용하였다.The composition prepared in item 1 was used as a sample, and each material of the composition was used as a comparative sample for comparison.
2-1. 총 폴리페놀 함량2-1. Total polyphenol content
총 폴리페놀 함량분석은 Gutfinger의 방법을 변형하여 측정하였다. 즉, 시료 1㎖에 2%(w/v) Na2CO3 용액 1㎖를 가하여 3분간 상온에서 반응시킨 후, 50% Folin-Ciocalteu 시약 0.2㎖를 첨가하여 30분간 상온에서 반응시키고, 이 반응물 1㎖를 취하여 750㎚에서 흡광도를 측정하는 방법으로 측정하였다. 이때 표준농도 곡선은 EGCG(epigallocatechin gallate)를 이용하여 작성하였다.Total polyphenol content analysis was determined by modifying Gutfinger's method. That is, 1 ml of 2% (w/v) Na 2 CO 3 solution was added to 1 ml of the sample and reacted at room temperature for 3 minutes, then 0.2 ml of 50% Folin-Ciocalteu reagent was added and reacted at room temperature for 30 minutes. 1 ml was taken and measured by measuring absorbance at 750 nm. At this time, the standard concentration curve was prepared using EGCG (epigallocatechin gallate).
이의 결과, 도 1 및 표 1과 같이, 총 폴리페놀 함량은 비교예 4가 가장 높은 것으로 나타났다.As a result, as shown in Figure 1 and Table 1, the total polyphenol content was found to be the highest in Comparative Example 4.
2-2. 세포독성 실험2-2. Cytotoxicity test
인간 간암 세포주(HepG2)를 대상으로 본 발명 조성물의 세포독성 여부를 검증하였다.The cytotoxicity of the composition of the present invention was verified against human liver cancer cell line (HepG2).
먼저 96-웰 플레이트의 각 웰에 HepG2를 200㎕(2x104 세포/웰) 분주하고 CO2 배양기에서 24시간 배양한 후 각 시료를 세포 배양액의 0.5%(v/v) 농도로 처리하고 CO2 배양기에서 다시 12시간 동안 배양하였다. 이후 MTT 분석으로 세포의 생존율을 측정하였다. 즉, 살아있는 세포의 미토콘드리아에 있는 산화환원효소인 mitochondrial dehydrogenase에 의해 MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5diphenyl-tetrazolium bromide)가 blue formazan(DMSO에 용해되어 570㎚ 파장에서 흡광)을 형성하는 현상을 이용하였다. 96-웰 플레이트에 MTT 용액(5㎎/㎖ in PBS) 20㎕를 처리하고 CO2 배양기에서 2시간 배양한 다음 상등액을 제거한 뒤 DMSO를 웰 당 200㎕ 씩 넣고 30분간 세포막 및 blue formazan을 용해하였다. ELISA 리더로 570㎚에서 흡광도를 측정하고 세포생존율을 측정하였다.First, 200 μl (2x10 4 cells/well) of HepG2 was dispensed into each well of a 96-well plate, cultured in a CO 2 incubator for 24 hours, and then each sample was treated at a concentration of 0.5% (v/v) of the cell culture medium and CO 2 Incubated again for 12 hours in an incubator. Then, cell viability was measured by MTT assay. That is, MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5diphenyl-tetrazolium bromide) is dissolved in blue formazan (DMSO at 570 nm) by mitochondrial dehydrogenase, an oxidoreductase in the mitochondria of living cells. absorption at a wavelength) was used. A 96-well plate was treated with 20 μl of MTT solution (5 mg/ml in PBS), incubated for 2 hours in a CO 2 incubator, then the supernatant was removed, and 200 μl of DMSO was added per well to dissolve the cell membrane and blue formazan for 30 minutes. . Absorbance was measured at 570 nm with an ELISA reader, and cell viability was measured.
이의 결과, 도 2 및 표 2와 같이, 실시예 1 및 비교예 1 내지 6은 세포 배양액의 0.5%(5000ppm)라는 높은 농도에서도 새포생존율이 80% 이상으로 세포독성이 없음을 알 수 있었다.As a result, as shown in FIG. 2 and Table 2, Example 1 and Comparative Examples 1 to 6 showed no cytotoxicity with a cell viability of 80% or more even at a high concentration of 0.5% (5000 ppm) of the cell culture medium.
2-3. 산 중화효과2-3. acid neutralizing effect
비이커에 0.1M 100㎖ 염산(HCl) 수용액을 담고 실시예 1 및 비교예 1 내지 6의 시료를 각각 1g씩 첨가한 후 실온에서 1시간 반응시켰다. 지시약으로 페놀프탈레인을 100㎕ 첨가한 후 0.1M 수산화나트륨(NaOH)으로 적정하여 각 시료에서 중화되지 않은 염산을 측정하였다.A 0.1 M 100 ml hydrochloric acid (HCl) aqueous solution was placed in a beaker, 1 g each of the samples of Example 1 and Comparative Examples 1 to 6 was added, and reacted at room temperature for 1 hour. After adding 100 μl of phenolphthalein as an indicator, titration was performed with 0.1 M sodium hydroxide (NaOH) to measure unneutralized hydrochloric acid in each sample.
이의 결과, 도 3 및 표 3과 같이, 실시예 1의 산 중화효과가 가장 높은 것으로 나타났다.As a result, as shown in FIG. 3 and Table 3, the acid neutralization effect of Example 1 was found to be the highest.
2-4. 항염증 효과2-4. anti-inflammatory effect
염증을 유발하는 주요 효소인 COX-2(cyclooxygenase-2)의 활성을 저해하는 효능을 알아보기 위해서 COX-2 효소의 기질인 아라키돈산(arachidonic acid)을 사용하여 헤마틴(hematin)의 산화를 유도하여 변색되는 현상을 이용하여 측정하였다.In order to investigate the efficacy of inhibiting the activity of COX-2 (cyclooxygenase-2), a major enzyme that induces inflammation, arachidonic acid, a substrate of COX-2 enzyme, is used to induce oxidation of hematin. It was measured using the phenomenon of discoloration.
구체적으로, 1.5㎖ 튜브에 COX-2 효소 10㎕, heme 10㎕, 반응 완충액 950㎕를 넣고 시료 20㎕를 첨가한 후 5분간 37℃에서 안정화하고 여기에 아라키돈산 10㎕를 넣고 2분간 37℃에서 반응시킨 후 1M HCl 50㎕를 넣고 반응을 정지하였다. SnCl2 100㎕를 넣고 잘 섞어준 후 상온에서 5분간 안정화시키고 반응액을 EIA 완충액으로 2000배, 4000배 희석하고 이를 프로스타그란딘 항체가 코팅된 96-웰 플레이트에 50㎕ 분주 후 PGs screening AChE tracer를 50㎕와 Antiserum을 50㎕ 첨가한 후 18시간 동안 상온에서 반응시켰다. 웰을 완충액으로 5회 세척한 후 Ellman's reagent를 200㎕ 넣고 60분간 발색한 후 410㎚의 파장에서 흡광도를 측정하였다. COX 활성억제의 정도는 제조사의 방법을 준용하여 50% 억제하는 농도인 IC50 값으로 표시하였다.Specifically, put 10 μl of COX-2 enzyme, 10 μl of heme, and 950 μl of reaction buffer in a 1.5 ml tube, add 20 μl of sample, stabilize at 37°C for 5 minutes, add 10 μl of arachidonic acid to this, and heat 37°C for 2 minutes. After the reaction, 50 μl of 1M HCl was added to stop the reaction. After adding 100 μl of SnCl 2 , mixing well, stabilizing at room temperature for 5 minutes, diluting the reaction solution 2000-fold and 4000-fold with EIA buffer, dispensing 50 μl of it onto a 96-well plate coated with prostaglandin antibody, and then PGs screening AChE tracer at 50 After adding ul and 50 μl of Antiserum, they were reacted at room temperature for 18 hours. After washing the wells 5 times with a buffer solution, 200 μl of Ellman's reagent was added, followed by color development for 60 minutes, and absorbance was measured at a wavelength of 410 nm. The degree of COX activity inhibition was expressed as an IC 50 value, which is a concentration that inhibits 50% by applying the manufacturer's method.
이의 결과, 도 4 및 표 4와 같이, 실시예 1의 시료가 비교예 1 내지 6의 시료 대비 COX-2를 50% 저해하는 최소값인 IC50값이 75.28±5.27㎍/㎖로 가장 낮아서 항염증 효과가 가장 우수한 것으로 나타났다.As a result, as shown in FIG. 4 and Table 4, the sample of Example 1 had the lowest IC 50 value of 75.28 ± 5.27 μg / ml, which is the minimum value that inhibits COX-2 by 50% compared to the samples of Comparative Examples 1 to 6, resulting in anti-inflammatory The effect was found to be the best.
2-5. 속쓰림 개선 효과2-5. Heartburn improvement effect
건강한 20 내지 40대 성인남녀 21명을 대상으로 실시예 1 및 비교예 1 내지 6의 시료를 1회에 5g씩 1일에 식전 3회(5g/1회, 3회/1일) 5일간 섭취하면서 도 5의 설문지를 활용하여 매일 설문조사를 진행하고 피험자 21명의 결과를 평균하였다. 평가는 전혀 개선안됨 1점, 개선안됨 2점, 보통 3점, 개선됨 4점, 매우 개선됨 5점으로 하여 12가지 개선 증상에 대해 각각 조사하였다. 즉, 최저점 12 ~ 최고점 60점이며 평균점은 36점으로 설계하였다.Samples of Example 1 and Comparative Examples 1 to 6 were taken by 21 healthy men and women in their 20s to 40s, 5g at a time, 3 times a day before meals (5g/1 time, 3 times/1 day) for 5 days. While using the questionnaire of FIG. 5, the questionnaire was conducted every day, and the results of 21 subjects were averaged. The evaluation was evaluated for 12 improvement symptoms, with 1 point not improved at all, 2 points not improved, 3 points moderate, 4 points improved, and 5 points very improved. That is, the lowest point is 12 ~ the highest point is 60 points, and the average point is designed as 36 points.
(전혀 개선안됨 1점, 개선안됨 2점, 보통 3점, 개선됨 4점, 매우 개선됨 5점)Heartburn Improvement Survey
(1 point not improved at all, 2 points not improved, 3 points moderate, 4 points improved, 5 points very much improved)
이의 결과, 도 6 및 표 5와 같이, 실시예 1의 시료가 비교예 1 내지 6의 시료 대비 1일차에서 5일차까지 매일 속쓰림 개선효과가 우수한 것으로 조사되었다.As a result, as shown in FIG. 6 and Table 5, the sample of Example 1 was found to have an excellent daily heartburn improvement effect from the 1st day to the 5th day compared to the samples of Comparative Examples 1 to 6.
Claims (8)
상기 조성물은 벌꿀, 감식초 및 올리고당 중에서 선택된 하나 이상을 더 포함하는, 조성물.According to claim 1,
The composition further comprises at least one selected from honey, persimmon vinegar and oligosaccharides.
상기 조성물은 분말, 과립, 정제, 환, 캡슐 또는 액상 형태인, 조성물.According to claim 1,
Wherein the composition is in powder, granule, tablet, pill, capsule or liquid form.
상기 조성물은 벌꿀, 감식초 및 올리고당 중에서 선택된 하나 이상을 더 포함하는, 조성물.According to claim 5,
The composition further comprises at least one selected from honey, persimmon vinegar and oligosaccharides.
상기 조성물은 분말, 과립, 정제, 환, 캡슐 또는 액상 형태인, 조성물.
According to claim 5,
Wherein the composition is in powder, granule, tablet, pill, capsule or liquid form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200114308A KR102474418B1 (en) | 2020-09-08 | 2020-09-08 | Composition for improving or preventing heartburn |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200114308A KR102474418B1 (en) | 2020-09-08 | 2020-09-08 | Composition for improving or preventing heartburn |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220033582A KR20220033582A (en) | 2022-03-17 |
KR102474418B1 true KR102474418B1 (en) | 2022-12-08 |
Family
ID=80936031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200114308A KR102474418B1 (en) | 2020-09-08 | 2020-09-08 | Composition for improving or preventing heartburn |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102474418B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102623645B1 (en) | 2023-10-12 | 2024-01-11 | 농업회사법인 온양바이오 주식회사 | Method for producing a composition comprising atractylodis rhizoma alba for improvving heartbum and a composition comprising atractylodis rhizoma alba produced thereby |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102115398B1 (en) * | 2018-11-20 | 2020-05-27 | 인산죽염 주식회사 | Functional food compound having antioxidant property and allergic dermatitis treatment property and method for manufacturing the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101291405B1 (en) * | 2011-12-30 | 2013-07-30 | 김윤수 | A Bamboo Salt Using Wood-cultivated Ginseng, A Bamboo Salt Capsule Using Wood-cultivated Ginseng and A Manufacturing Method thereof |
KR101756775B1 (en) * | 2015-10-15 | 2017-07-26 | 남부대학교산학협력단 | Compositions for treating, improving or preventing for diseases derived from helicobacter pylori |
KR102122283B1 (en) | 2018-10-04 | 2020-06-19 | 정수현 | Beverage Containing Onion And Grain |
-
2020
- 2020-09-08 KR KR1020200114308A patent/KR102474418B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102115398B1 (en) * | 2018-11-20 | 2020-05-27 | 인산죽염 주식회사 | Functional food compound having antioxidant property and allergic dermatitis treatment property and method for manufacturing the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102623645B1 (en) | 2023-10-12 | 2024-01-11 | 농업회사법인 온양바이오 주식회사 | Method for producing a composition comprising atractylodis rhizoma alba for improvving heartbum and a composition comprising atractylodis rhizoma alba produced thereby |
Also Published As
Publication number | Publication date |
---|---|
KR20220033582A (en) | 2022-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gondi et al. | Ethanol extract of mango (Mangifera indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats | |
Mushtaq et al. | RSM based optimized enzyme-assisted extraction of antioxidant phenolics from underutilized watermelon (Citrullus lanatus Thunb.) rind | |
Adefegha et al. | Inhibitory effects of aqueous extract of two varieties of ginger on some key enzymes linked to type-2 diabetes in vitro | |
De Caluwé et al. | Tamarindus indica L.–A review of traditional uses, phytochemistry and pharmacology | |
Oboh et al. | Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside induced lipid peroxidation in rats’ pancreas by phenolic extracts of avocado pear leaves and fruit | |
Ghasemi et al. | Influence of environmental factors on antioxidant activity, phenol and flavonoids contents of walnut (Juglans regia L.) green husks | |
KR101383276B1 (en) | Black Chokeberry concentrate and the manufacturing method | |
Arasaretnam et al. | Nutritional and mineral composition of selected green leafy vegetables | |
Dagadkhair et al. | Jamun (Syzygium cumini) Skeels: a traditional therapeutic tree and its processed food products | |
Sangiovanni et al. | A bio-guided approach for the development of a chestnut-based proanthocyanidin-enriched nutraceutical with potential anti-gastritis properties | |
Chaubey et al. | Evaluation of debittered and germinated fenugreek (Trigonella foenum graecum L.) seed flour on the chemical characteristics, biological activities, and sensory profile of fortified bread | |
Selvamuthukumaran et al. | Development of spiced seabuckthorn [Elaeagnus rhamnoides (L.) a. Nelson syn. Hippophae rhamnoides L.] mixed fruit squash | |
Kaur et al. | Characterization of Antioxidants and Hypoglycemic Potential of Pomegranate Grown in I ndia: A Preliminary Investigation | |
Oboh et al. | Inhibitory effect of polyphenolic–rich extract from Cola nitida (Kolanut) seed on key enzyme linked to type 2 diabetes and Fe2+ induced lipid peroxidation in rat pancreas in vitro | |
Parra et al. | An overview on various aspects of plant Berberis Lycium Royale | |
KR102474418B1 (en) | Composition for improving or preventing heartburn | |
López‐Martínez et al. | Effect of processing of corn for production of masa, tortillas and tortilla chips on the scavenging capacity of reactive nitrogen species | |
Adefegha | Impact of pasting on starch composition, estimated glycemic index, phenolic constituents, antioxidant activities and antidiabetic properties of flour produced from cocoyam (Colocasia esculenta) corm | |
Adefegha et al. | Pasting alters glycemic index, antioxidant activities, and starch‐hydrolyzing enzyme inhibitory properties of whole wheat flour | |
Abbe et al. | Antioxidant content in Solanum anguivi Lam berries as affected by cooking at different stages of ripening | |
KR102115398B1 (en) | Functional food compound having antioxidant property and allergic dermatitis treatment property and method for manufacturing the same | |
Chanhan et al. | Effect of agricultural model of using fertilizer, harvesting time and extraction method on phytochemical contents and antioxidant activities from mulberry leaves grown in Maha Sarakham Province, Thailand | |
CN104397259A (en) | Grosvenor momordica fruit tea for clearing heat from throat and benefitting throat and manufacturing method thereof | |
Kaur et al. | Phytochemical and pharmacological characteristics of phalsa (Grewia asiatica L.): A comprehensive review | |
Hien et al. | Study on changes in chemical compositions and bioactive compounds in POUTERIA CAMPECCHIANA fruit during storage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |